metformin has been researched along with Cancer of Mediastinum in 1 studies
Metformin: A biguanide hypoglycemic agent used in the treatment of non-insulin-dependent diabetes mellitus not responding to dietary modification. Metformin improves glycemic control by improving insulin sensitivity and decreasing intestinal absorption of glucose. (From Martindale, The Extra Pharmacopoeia, 30th ed, p289)
metformin : A member of the class of guanidines that is biguanide the carrying two methyl substituents at position 1.
| Excerpt | Relevance | Reference |
|---|---|---|
| "NUT midline carcinoma is a rare entity arising primarily in the midline of teenagers and young adults." | 1.42 | NUT Midline Carcinoma: Morphoproteomic Characterization with Genomic and Therapeutic Correlates. ( Brown, RE; McGuire, MF; Sun, H; Zhang, S, 2015) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sun, H | 1 |
| McGuire, MF | 1 |
| Zhang, S | 1 |
| Brown, RE | 1 |
1 other study available for metformin and Cancer of Mediastinum
| Article | Year |
|---|---|
NUT Midline Carcinoma: Morphoproteomic Characterization with Genomic and Therapeutic Correlates.
Topics: Adolescent; Adult; Carcinoma; Enhancer of Zeste Homolog 2 Protein; Female; Humans; Immunohistochemis | 2015 |